Guilin Pharma, a Fosun Subsidiary, Partners with CleveXel of France
September 04, 2014 at 09:23 AM EDT
Guilin Pharmaceutical, a subsidiary of Fosun Pharma, and CleveXel Pharma of France will collaborate to increase production of artemisinin, Guilin's malaria treatment. Guilin is one of the world's largest producers of artemisinin, a drug that was originally a TCM but is now grown in yeast. Guilin has WHO pre-certification to sell artemisinin-based malaria products in developing countries. More details.... Stock Symbol: (SHA: 600196; HK: 2196) Share this with colleagues: // //